The Opioid Crisis in NJ: Current Trends and Evidence-Based Treatment Options
ID: 4969WEBThis interactive webinar will discuss the latest developments and trends regarding natural opiates, semi-synthetic opioids, and synthetic opioids. Participants will be able to identify national and local NJ trends with regards to prescribing practices and new legislation, opioid overdoses and trends with opioid use. Participants will be able to distinguish the difference between which drugs are considered naturally occurring opiates, which are considered semi-synthetic opioids and which are considered synthetic opioids. Participants will be introduced into the assessment of and treatment of Opioid Use Disorders via the DSM 5 criteria, the latest nationally recognized medicated assisted treatment and the non-medication assisted treatment approaches when working with clients. Participants will be able to identify three different medicated assisted treatments (MAT), and discussion of medicinal marijuana being added as an MAT option. Webinar participants will be introduced to a harm reduction treatment paradigm and will be able to identify at least 3 different harm reduction principles when working with clients. Finally, participants will engage in an interactive case that will develop throughout the webinar and have different objectives (e.g., assessing a proper level of care, and then incorporating a harm reduction treatment orientation with the client in regards to their MAT decision process). [This webinar will complete your prescription opioid social work license requirement]
Fee: $60.00
Continuing Ed. Hours (CEH): 2.0 General, 1.0 Prescription Opioids
Webinar ObjectivesAt the conclusion of the webinar, participants will be able to:
Differentiate the major elements the Federal Government uses when classifying drugs from schedule 1 through schedule 5.
Identify national and local NJ trends with regards to prescribing practices and new legislation, opioid overdoses and trends with opioid use.
Distinguish the difference between which drugs are considered naturally occurring opiates, which are considered semi-synthetic opioids and which are considered synthetic opioids.
List and describe three different best practice medication assisted therapies when working with clients who have an opioid use disorder.,br>
Webinar Outline9:30 am The Controlled Substances Act
Overview of the scheduling of controlled substances.
9:40 am The History of Opioids and the Latest Terminology
History of classifying/prohibiting opiates
Defining Terminology: natural opiates, semi-synthetic opioids, and synthetic opioids.
10:00 am Prescription Opioids
The history of prescription opioids
Changes in prescribing practices (1990s)
National prescribing trends
NJ prescription opioid law limiting first time prescriptions
10:45 am Medication Assisted Treatments
Discussion of the use of MAT, newer names given for MAT (MOUD Medications for Opioid Use Disorders) and discussion of person bias with MATs
Revised Temporary Methadone medication guidelines 2020
Revised Buprenorphine medication guidelines 2021
Medicinal marijuana as an MAT option for NJ residents
11:30 am National Overdose Trends and NJ Specific Trends
National overdose trends up until 2021 (CDC information)
Introduction to Narcan
NJ specific opioid overdose and Narcan implementation trends
12:20 pm Conclusion/Q&A
Target AudienceSocial Workers and Allied ProfessionalsContent LevelBeginner - AdvancedWebinar Completion RequirementsTo earn CE credit, social workers must log in at the scheduled time, attend the entire course and complete an online course evaluation. Certificates of completion will be emailed within 10 business days of course completion.
System Requirements
- Operating Systems: Windows XP or higher, MacOS 9 or higher, Android 4.0 or higher
- Internet Browser: Internet Explorer 9.0 or higher, Google Chrome, Firefox 10.0 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible.
About the InstructorGlenn Duncan, LPC, LCADC, CCS, ACS, has been working in the behavioral healthcare field for thirty years. He has lectured nationally on many topics including clinical supervision. He is a Licensed Professional Counselor, a Licensed Clinical Alcohol/Drug Counselor, a Certified Clinical Supervisor, and an Approved Clinical Supervisor. Glenn is currently the owner of Advanced Counselor Training, LLC. For 15 years (2003-2018) Glenn served as the Executive Director at Hunterdon Drug Awareness Program, Inc. (HDAP).
